Holen Sie sich die Stockscreener-App
1.74
1.75%
0.03
Handel nachbörslich:
1.70
-0.04
-2.30%
Schlusskurs vom Vortag:
$1.71
Offen:
$1.69
24-Stunden-Volumen:
269.75K
Relative Volume:
0.47
Marktkapitalisierung:
$65.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.75%
1M Leistung:
-2.25%
6M Leistung:
+4.19%
1J Leistung:
-51.12%
1-Tages-Spanne:
$1.6775
$1.755
1-Wochen-Bereich:
$1.58
$1.755
52-Wochen-Spanne:
$1.23
$4.00
Metagenomi Inc Stock (MGX) Company Profile
Firmenname
Metagenomi Inc
Sektor
Branche
Telefon
(510) 871-4880
Adresse
5959 HORTON STREET, EMERYVILLE
Vergleichen Sie MGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.74 | 64.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-03-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-03-05 | Eingeleitet | TD Cowen | Outperform |
| 2024-03-05 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Metagenomi Inc Aktie (MGX) Neueste Nachrichten
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Aug Fed Impact: Is Metagenomi Inc stock undervalued vs historical averagesCEO Change & Reliable Breakout Forecasts - moha.gov.vn
Head to Head Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Metagenomi (NASDAQ:MGX) - Defense World
Short Interest in Metagenomi, Inc. (NASDAQ:MGX) Grows By 27.1% - Defense World
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com UK
Metagenomi Earnings Notes - Trefis
CEO Moves: Can Metagenomi Inc stock weather global recession2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
Why analysts upgrade Metagenomi Inc. stock2025 Price Targets & High Win Rate Trade Alerts - Улправда
Will Metagenomi Inc. stock attract ESG investorsEarnings Risk Summary & Free Low Drawdown Momentum Trade Ideas - Улправда
Why Metagenomi Inc. stock attracts global investorsJuly 2025 Weekly Recap & Real-Time Market Trend Scan - Улправда
Is Metagenomi Inc. stock attractive after correctionJuly 2025 Market Mood & Fast Entry and Exit Trade Plans - Улправда
Is Metagenomi Inc. stock in correction or buying zoneMarket Risk Report & Community Shared Stock Ideas - bolumsonucanavari.com
Is Metagenomi Inc. stock recession proofJuly 2025 Summary & High Accuracy Investment Entry Signals - Улправда
Is Metagenomi Inc. stock positioned well for digital economy2025 Technical Patterns & Expert Approved Trade Ideas - DonanımHaber
Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock - Investing.com India
Metagenomi CFO Wapnick sells $2792 in shares By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock By Investing.com - Investing.com Australia
Metagenomi general counsel Wein sells $352 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock - Investing.com
Metagenomi general counsel Wein sells $352 in stock - Investing.com
Will Metagenomi Inc. stock deliver consistent dividendsBull Run & Technical Pattern Based Signals - Newser
Pura Vida Investments LLC Grows Stock Position in Metagenomi, Inc. $MGX - MarketBeat
Metagenomi’s general counsel Wein sells $360 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 By Investing.com - Investing.com Canada
Metagenomi CFO Wapnick sells $2852 in shares By Investing.com - Investing.com Canada
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 - Investing.com India
Metagenomi CFO Wapnick sells $2852 in shares - Investing.com
CEO Irish Surrenders 1,602 Of Metagenomi Inc [MGX] - TradingView
Metagenomi’s general counsel Wein sells $360 in stock - Investing.com
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - marketscreener.com
Metagenomi (Nasdaq: MGX) to unveil APOC3 preclinical data from Ionis collaboration at 2025 Nature conference - Stock Titan
Metagenomi, Inc. (MGX) 5.71% in After-hours: Strong Investor Interest - Stocks Telegraph
Finanzdaten der Metagenomi Inc-Aktie (MGX)
Es liegen keine Finanzdaten für Metagenomi Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):